Amedisys Net Debt from 2010 to 2024

AMED Stock

USD 90.16 0.16 0.18%

Amedisys' Net Debt is increasing over the years with slightly volatile fluctuation. Overall, Net Debt is expected to go to about 378.8 M this year. Net Debt is the total debt of Amedisys minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1993-12-31

Previous Quarter

317.3 M

Current Value

223.1 M

Quarterly Volatility

154.3 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Amedisys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amedisys' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.6 M, Interest Expense of 32.8 M or Selling General Administrative of 333.3 M, as well as many indicators such as Price To Sales Ratio of 0.86, Dividend Yield of 3.0E-4 or PTB Ratio of 2.57. Amedisys financial statements analysis is a perfect complement when working with Amedisys Valuation or Volatility modules.

Check out the analysis of Amedisys Correlation against competitors.

For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Latest Amedisys' Net Debt Growth Pattern

Below is the plot of the Net Debt of Amedisys over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Amedisys' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amedisys' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Amedisys Net Debt Regression Statistics

	Arithmetic Mean	180,867,277
	Coefficient Of Variation	100.34
	Mean Deviation	156,759,665
	Median	97,435,000
	Standard Deviation	181,477,554
	Sample Variance	32934.1T
	Range	515.8M
	R-Value	0.78
	Mean Square Error	13827.6T
	R-Squared	0.61
	Significance	0.0006
	Slope	31,697,132
	Total Sum of Squares	461077.4T

Amedisys Net Debt History

	2024	378.8 M
	2023	360.8 M
	2022	497.4 M
	2021	502.9 M
	2020	225.2 M
	2019	295.8 M
	2018	-12.8 M

Other Fundumenentals of Amedisys

Net Debt To E B I T D A

Amedisys Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Intangible Assets	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.91	0.95	0.6	0.95	0.99	0.95	0.91	0.37	0.53	0.94	-0.92	-0.24	0.98	0.89	0.77	-0.81	0.29	0.88	0.85	0.4	0.72	0.8	0.91	-0.64	0.81
Total Stockholder Equity	0.99		0.87	0.93	0.64	0.97	0.97	0.95	0.9	0.38	0.58	0.92	-0.9	-0.24	0.97	0.88	0.75	-0.75	0.27	0.84	0.85	0.35	0.71	0.79	0.88	-0.62	0.79
Net Debt	0.91	0.87		0.91	0.55	0.8	0.92	0.76	0.84	0.49	0.37	0.99	-0.88	-0.18	0.93	0.91	0.73	-0.88	0.34	0.91	0.76	0.5	0.77	0.65	0.95	-0.56	0.67
Retained Earnings	0.95	0.93	0.91		0.47	0.87	0.94	0.85	0.91	0.43	0.29	0.94	-0.95	-0.37	0.98	0.88	0.86	-0.92	0.49	0.94	0.81	0.63	0.78	0.81	0.95	-0.66	0.84
Accounts Payable	0.6	0.64	0.55	0.47		0.69	0.58	0.56	0.37	0.43	0.78	0.52	-0.59	-0.05	0.57	0.72	0.4	-0.33	0.07	0.26	0.69	0.06	0.31	0.08	0.51	-0.6	0.17
Net Receivables	0.95	0.97	0.8	0.87	0.69		0.92	0.97	0.83	0.31	0.63	0.84	-0.88	-0.29	0.91	0.84	0.75	-0.67	0.34	0.74	0.86	0.33	0.66	0.73	0.8	-0.65	0.74
Total Liab	0.99	0.97	0.92	0.94	0.58	0.92		0.93	0.9	0.33	0.49	0.95	-0.91	-0.23	0.98	0.89	0.78	-0.84	0.31	0.89	0.84	0.44	0.69	0.79	0.92	-0.67	0.81
Total Current Assets	0.95	0.95	0.76	0.85	0.56	0.97	0.93		0.85	0.22	0.57	0.82	-0.83	-0.3	0.9	0.78	0.72	-0.66	0.29	0.76	0.82	0.3	0.63	0.82	0.78	-0.58	0.81
Short Term Debt	0.91	0.9	0.84	0.91	0.37	0.83	0.9	0.85		0.42	0.29	0.87	-0.79	-0.2	0.89	0.76	0.68	-0.75	0.33	0.88	0.68	0.39	0.72	0.86	0.86	-0.42	0.85
Current Deferred Revenue	0.37	0.38	0.49	0.43	0.43	0.31	0.33	0.22	0.42		0.16	0.44	-0.43	-0.22	0.41	0.43	0.25	-0.39	0.17	0.35	0.35	0.22	0.49	0.1	0.5	-0.08	0.08
Common Stock	0.53	0.58	0.37	0.29	0.78	0.63	0.49	0.57	0.29	0.16		0.39	-0.42	0.12	0.42	0.57	0.23	-0.08	-0.25	0.14	0.67	-0.26	0.34	0.17	0.36	-0.36	0.28
Long Term Debt	0.94	0.92	0.99	0.94	0.52	0.84	0.95	0.82	0.87	0.44	0.39		-0.89	-0.23	0.96	0.91	0.73	-0.88	0.33	0.95	0.79	0.47	0.79	0.74	0.96	-0.54	0.74
Treasury Stock	-0.92	-0.9	-0.88	-0.95	-0.59	-0.88	-0.91	-0.83	-0.79	-0.43	-0.42	-0.89		0.42	-0.96	-0.89	-0.93	0.89	-0.52	-0.85	-0.9	-0.68	-0.76	-0.68	-0.91	0.78	-0.74
Property Plant Equipment	-0.24	-0.24	-0.18	-0.37	-0.05	-0.29	-0.23	-0.3	-0.2	-0.22	0.12	-0.23	0.42		-0.34	-0.19	-0.54	0.45	-0.54	-0.35	-0.41	-0.61	-0.25	-0.37	-0.3	0.36	-0.37
Good Will	0.98	0.97	0.93	0.98	0.57	0.91	0.98	0.9	0.89	0.41	0.42	0.96	-0.96	-0.34		0.91	0.83	-0.89	0.4	0.92	0.86	0.54	0.75	0.79	0.95	-0.68	0.81
Intangible Assets	0.89	0.88	0.91	0.88	0.72	0.84	0.89	0.78	0.76	0.43	0.57	0.91	-0.89	-0.19	0.91		0.71	-0.82	0.34	0.81	0.9	0.43	0.79	0.58	0.94	-0.63	0.68
Short Term Investments	0.77	0.75	0.73	0.86	0.4	0.75	0.78	0.72	0.68	0.25	0.23	0.73	-0.93	-0.54	0.83	0.71		-0.84	0.65	0.75	0.78	0.84	0.63	0.62	0.76	-0.83	0.7
Net Tangible Assets	-0.81	-0.75	-0.88	-0.92	-0.33	-0.67	-0.84	-0.66	-0.75	-0.39	-0.08	-0.88	0.89	0.45	-0.89	-0.82	-0.84		-0.57	-0.93	-0.73	-0.78	-0.71	-0.69	-0.93	0.66	-0.73
Total Permanent Equity	0.29	0.27	0.34	0.49	0.07	0.34	0.31	0.29	0.33	0.17	-0.25	0.33	-0.52	-0.54	0.4	0.34	0.65	-0.57		0.44	0.37	0.81	0.33	0.32	0.41	-0.5	0.33
Long Term Debt Total	0.88	0.84	0.91	0.94	0.26	0.74	0.89	0.76	0.88	0.35	0.14	0.95	-0.85	-0.35	0.92	0.81	0.75	-0.93	0.44		0.71	0.59	0.79	0.85	0.94	-0.47	0.85
Capital Surpluse	0.85	0.85	0.76	0.81	0.69	0.86	0.84	0.82	0.68	0.35	0.67	0.79	-0.9	-0.41	0.86	0.9	0.78	-0.73	0.37	0.71		0.46	0.75	0.62	0.85	-0.71	0.73
Deferred Long Term Liab	0.4	0.35	0.5	0.63	0.06	0.33	0.44	0.3	0.39	0.22	-0.26	0.47	-0.68	-0.61	0.54	0.43	0.84	-0.78	0.81	0.59	0.46		0.44	0.37	0.55	-0.66	0.45
Long Term Investments	0.72	0.71	0.77	0.78	0.31	0.66	0.69	0.63	0.72	0.49	0.34	0.79	-0.76	-0.25	0.75	0.79	0.63	-0.71	0.33	0.79	0.75	0.44		0.66	0.82	-0.25	0.71
Short Long Term Debt	0.8	0.79	0.65	0.81	0.08	0.73	0.79	0.82	0.86	0.1	0.17	0.74	-0.68	-0.37	0.79	0.58	0.62	-0.69	0.32	0.85	0.62	0.37	0.66		0.74	-0.32	0.95
Net Invested Capital	0.91	0.88	0.95	0.95	0.51	0.8	0.92	0.78	0.86	0.5	0.36	0.96	-0.91	-0.3	0.95	0.94	0.76	-0.93	0.41	0.94	0.85	0.55	0.82	0.74		-0.58	0.79
Net Working Capital	-0.64	-0.62	-0.56	-0.66	-0.6	-0.65	-0.67	-0.58	-0.42	-0.08	-0.36	-0.54	0.78	0.36	-0.68	-0.63	-0.83	0.66	-0.5	-0.47	-0.71	-0.66	-0.25	-0.32	-0.58		-0.45
Capital Stock	0.81	0.79	0.67	0.84	0.17	0.74	0.81	0.81	0.85	0.08	0.28	0.74	-0.74	-0.37	0.81	0.68	0.7	-0.73	0.33	0.85	0.73	0.45	0.71	0.95	0.79	-0.45

Click cells to compare fundamentals

About Amedisys Financial Statements

Amedisys stakeholders use historical fundamental indicators, such as Amedisys' Net Debt, to determine how well the company is positioned to perform in the future. Although Amedisys investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amedisys' assets and liabilities are reflected in the revenues and expenses on Amedisys' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amedisys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	360.8 M	378.8 M
Net Debt To EBITDA	1.66	1.58

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:

How To Invest In Amedisys

Details

Is Amedisys Stock a good investment?

Details

What is Amedisys' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Amedisys Correlation against competitors.

For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.35)

Earnings Share

2.52

Revenue Per Share

71.004

Quarterly Revenue Growth

0.057

Return On Assets

0.0627

The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amedisys Net Debt from 2010 to 2024

Latest Amedisys' Net Debt Growth Pattern

Amedisys Net Debt Regression Statistics

Amedisys Net Debt History

Other Fundumenentals of Amedisys

Amedisys Net Debt component correlations

About Amedisys Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY